AbbVie Inc. Soars: Shares Climb 1.19% on Strong Trading Day
Biopharmaceutical Leader Demonstrates Robust Market Performance
New York, NY – August 31 , 2025 – AbbVie Inc. (NYSE: ABBV) experienced a highly positive close to its trading session, with its stock price increasing by an impressive $2.48, or 1.19%, to settle at $210.40 USD. This significant gain reflects strong investor confidence in the biopharmaceutical giant.
Throughout the day’s trading, AbbVie’s shares saw dynamic movement, reaching a high of $211.00 and a low of $207.90. The positive momentum continued into after-hours trading, with an additional gain of $1.10, or 0.52%, pushing the price to $211.50.
AbbVie maintains a substantial market capitalization of 37.19 KCr, underscoring its prominent position in the pharmaceutical industry. The company’s P/E ratio is currently at 100.13, and it offers a dividend yield of 3.12%, making it an attractive option for investors seeking both growth and income.
With a 52-week high of $218.66 and a 52-week low of $163.81, today’s performance brings AbbVie closer to its annual peak, suggesting sustained growth and market optimism. The quarterly dividend amount stands at $1.64, further enhancing its appeal to shareholders.
AbbVie’s strong showing today highlights its continued success and positive trajectory in the market, providing good news for investors as the trading week draws to a close.
Would you like an image to go along with this article?
